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Background: Sialadenoma papilliferum is a benign rare condition of salivary glands showing a characteristic pa-
pillary growth of the ductal epithelium that ends up being confused with more frequent lesions of the oral cavity. 
Objectives: To perform a bibliometric analysis of all articles about Sialadenoma papilliferum in the oral cavity and 
to add a singular case report of Sialadenoma in the lower lip. 
Material and Methods: A total of 36 publications referring to Sialadenoma papilliferum in the oral cavity from the 
PubMed platform was reviewed. The specific data were collected, and a bibliometric analysis was performed using 
Microsoft Excel. The results obtained were then compared with this new case report. 
Results: The people most affected with sialadenoma were white males at the average age of 56. The lesion was 
asymptomatic, usually white or red, with an average size of 1.4 cm, and the palate was by far the most affected site. 
The majority of the lesions were excised, and only two cases indicated recurrence.
Conclusions: With surgical removal, Sialadenoma papilliferum has a favorable prognosis and no further treatment 
is required. Due to few recorded cases of recurrence, a long follow-up period is recommended to ensure that the 
lesion does not redevelop.
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Introduction
Abrams and Finck first used the term Sialadenoma papi-
lliferum (SP) in 1969 to describe two cases of an unusual 
neoplastic salivary gland proliferation that appears to be 
quite similar morphologically to the Syringadenoma pa-
pilliferum originating from the sweat glands (1). There-
fore, SP is a distinctive rare benign lesion of the salivary 
glands (2), showing a characteristic papillary growth of 
ductal epithelium (3), and is classified as a ductal pa-
pilloma (4). SP’s origins have been controversial (5). 
Abrams and Finck believe that it arises from myoepi-
thelial cells (1), but others have proposed that it is a re-
sult of focal hyperplasia and metaplastic phenomena of 
intercalated or excretory duct cells, following blockage 
of a salivary gland duct (6). SP clinical features can mi-
mic other lesions, such as mucocele. It often involves 
the palate, lip, and buccal mucosa, and it usually affects 
old men and rarely children (7,8). Surgical excision is an 
adequate treatment for the lesion with a good prognosis 
because local recurrence is rare (9,10). The present arti-
cle is intended to perform a bibliometric analysis of all 
articles in the Pubmed platform about Sialadenoma pa-
pilliferum in the oral cavity and a literature review and 
to add a singular case report of Sialadenoma occurring 
in the lower lip.
Material and Methods
A bibliometric study of scientific literature was carried 
out with articles from the PubMed platform with the fo-
llowing descriptors: “Sialadenoma papilliferum,” “oral 
cavity,” and “case report.” A total of 65 articles were 
found, but those that did not concern the topic of inte-
rest, were not case reports, or included cases that did not 
occur in the oral cavity were excluded from the review. 
Consequently, 36 articles remained for the bibliometric 
analysis, which was performed using Microsoft Excel. 
The following indexes were taken into account: publi-
shing country, patient race, age at diagnosis, patient gen-
der, lesion occurrence site, lesion size, progression time, 
lesion color, symptoms, biopsy type, additional analysis, 
follow-up period, recurrence, and diagnostic hypothesis 
(data are given in Online Resource 1). Finally, the results 
obtained were compared with the case reported below.
A 20-year-old female with no medical history presented 
with a 2 cm x 1 cm painless nodular mass on the lower 
lip with trauma due to an orthodontic treatment (Fig. 1). 
The tumor was excised under local anesthesia, with a 
suspected clinical diagnosis of mucocele, and submitted 
for histopathological examination. Histologically, the 
lesion showed an exophytic papillary proliferation com-
posed of well-differentiated stratified squamous epithe-
lium, which merged with a glandular proliferation occu-
pying the submucosa (Fig. 2). The stratified squamous 
epithelium in the exophytic portion was hyperplastic 
with hyperkeratosis, parakeratosis, and focal hypergra-
Fig. 1: Nodular mass at the lower lip.
Fig. 2: Exophytic papillary proliferation composed of stratified 
squamous epithelium and glandular proliferation occupying the sub-
mucosa (H&E, original magnification: 10X).
nulosis. The squamous epithelium also showed spongio-
sis. Ductal structures showed an irregular outline with 
infoldings of the glands (Fig. 3). The ductal epithelium 
was composed of luminal columnar cells with abundant 
cytoplasm and basally located round nuclei. The con-
nective tissue showed chronic inflamation, and the mi-
nor salivary glands showed a normal appearance, along 
with the muscular and neural tissues. Based on these his-
tological findings, the diagnosis of SP was established. 
After a 17-month follow-up period, the patient showed 
no evidence of recurrence.
Results and Discussion
The 36 articles selected for our review presented 50 SP 
case reports (1-5,7-9,11-37). 
Publishing country – The country with the majority of 
publications was the United States of America (USA) 
with 18 (36%) cases. The second is Japan, which had 
one-third less cases than the USA with 6 (12%) cases. 
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The complete distribution of cases per country is displa-
yed on Table 1. 
Patient race – Of the 50 reported patients, 18 (36%) 
were white, 5 (10%) were Japanese, and 3 (6%) were 
black. The articles included only 1 (2%) brown patient 
and only 1 (2%) Arabic patient. The remaining 22 cases 
(44%) did not state the patient’s race.
Age at diagnostic – All 50 articles provided information 
about the affected patients’ ages (Table 2), showing that 
SP has been associated with every age group. The ave-
Fig. 3: Ductal structures showing an irregular outline with infold-
ings of the glands (H&E, original magnification: 20X).


















Table 1: Distribution of cases per country. Based on 
literature review.(1-5, 7-9, 11-37).
N = number  % = percentage.
Age at Diagnostic
Age range N %
0 - 9 1 2
10 - 19 1 2
20 - 29 1 2
30 - 39 4 8
40 - 49 6 12
50 - 59 15 30
60 - 69 12 24
70 - 79 9 18
80 - 89 1 2
90 - 99 0 0
Total 50 100
Table 2: Age at diagnostic range. Based on literature re-
view (1-5, 7-9, 11-37).
N = number  % = percentage.
rage patient age was 56 years, with a standard deviation 
of 16 years.
Patient gender – Of the 50 cases, 35 (70%) occurred in 
males, 14 (28%) were observed in females, and 1 (2%) 
patient’s gender was unknown.
Lesion occurrence site – The palate was the site with 
the highest incidence with 31 cases out of 50 (62%), fo-
llowed by the buccal mucosa with 4 (8%) cases and the 
parotid gland, also with 4 (8%) cases. All reported occu-
rrence sites are shown on Table 3. Of the cases, 21 (42%) 
occurred on the hard palate, 6 (12%) at the junction of 
the hard and soft palates, 1 (2%) on the soft palate, and 
3 (6%) of the cases did not specify in which part of the 




Buccal mucosa 4 8
Parotid gland 4 8
Retromolar pad area 3 6
Tongue 2 4
Upper lip 2 4
Floor of the mouth 2 4
Faucial pillar 1 2
Adenoids 1 2
Total 50 100
Table 3: Sialadenoma occurrence sites. Based on literature 
review (1-5, 7-9, 11-37).
N = number  % = percentage.
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Lesion size – The average lesion size was 1.4 cm with 
a standard deviation of 1.5 cm. A large majority of the 
lesions (41 out of 50, 82%) measured until 2 cm in the 
largest extent, 3 (6%) ranged from 2.1 to 4 cm, and only 
2 (4%) were larger than 4 cm. Of the articles, 4 (8%) did 
not include the lesion’s size.
Progression time – The average progression time was 52 
months, with a standard deviation of 60 months.
Lesion color – The data showed that 5 out of 50 lesions 
(10%) were white, 5 (10%) were red, 5 (10%) were whi-
tish velvet, and 4 (8%) were pink. Variances from these 
colors were also cited, as shown on Table 4.
Lesion Color
Color N %







somewhat pigmented 1 2
unknown 22 44
Total 50 100
Table 4: SP Lesion Color. Based on literature review (1-
5, 7-9, 11-37).
N = number  % = percentage.
Symptoms – In no case was the lesion reported as symp-
tomatic. Of the 50 cases, 12 (24%) were recorded as 
asymptomatic, and 38 (76%) did not include any men-
tion of symptoms.
Biopsy type – Of the 50 reviewed cases, 34 (68%) in-
cluded excision of the lesion, 2 (4%) included incisional 
biopsy before the excisional one, and 1 (2%) included an 
autopsy of the lesion. The biopsy type was not indicated 
in 13 (26%) cases.
Additional analysis – Of the 36 articles, 7 included an 
immunohistochemistry (IHC) study, and 1 included a 
human papillomavirus (HPV) polymerase chain reac-
tion (PCR) analysis. The 28 remaining articles did not 
include any analysis other than the histopathological 
examination.
Follow-up period – The average follow-up period was 
23 months.
Recurrence – Only 2 cases out of 50 (4%) indicated re-
currence of the SP lesion, 33 (66%) cases stated no re-
currence, and 15 (30%) cases didn’t refer to this subject.
Diagnostic hypothesis – Of the 50 cases consulted, 36 
diagnostic hypotheses were found. From the most to the 
least frequent: papilloma was the most mentioned, with 
11 (31%) citations, followed by carcinoma with 6 (17%) 
citations; fibroma with 4 (11%) citations; and salivary 
gland neoplasm, also with 4 (11%) citations. Other diag-
nostic hypotheses mentioned were: Fibroepithelial with 
3 (8%) citations, vascular lesion with 3 (8%) citations, 
mucocele with 2 (5%) citations, melanoma with 1 (3%) 
citation, verrucous leucoplakia with 1 (3%) citation and 
Warthin’s tumor with 1 (3%) citation.
SP is a rare neoplasm that accounts for less than 1% of 
salivary gland tumors and typically affects adults older 
than 50 (as seen on Table 2) (38). The youngest patient, 
two years old, was reported by Sawyer in 1986 (34), and 
the fourth youngest patient with SP, to our knowledge, is 
presented in this paper. Our bibliometric study (Online 
Resource 1) found only three SP cases published in Bra-
zil (Table 1), and all of them occurred in adult patients 
(11,18), which makes this case the first one involving 
a young patient in Brazil. The reason adults are more 
frequently affected is uncertain.
Our case analysis revealed that males were more often 
affected by SP than females according to the literature 
and that more than one-third of the patients were white 
(3,4,16). Nonetheless, to our knowledge, no other article 
has included race prevalence.
SP appears as an exophytic papillary growth of the 
mucosa with color ranging from white to red (Table 
4) (3,4,16). In this case, though, SP manifests itself as 
a nodular mass without papillary features, similar to 
another case in the upper lip buccal mucosa (12). The 
present SP size matches the one reported in the literatu-
re, as it does not exceed 2 cm (16). The majority of the 
cases reviewed (41 out of 50, 82%) match this criteria; 
however, five cases included SP lesions bigger than 2 cm 
(1,13,14,31,37).
The literature states that SP often involves the palate, lip, 
and buccal mucosa(10). Based on the articles consulted, 
the palate was indeed the site with the highest incidence 
with 31 cases out of 50 (Table 3). The buccal mucosa 
was the second most affected site but represented only 
8% of the cases, and the lip had a low incidence of 4%. 
The present case was the only one reported in the lower 
lip. We still have no explanation of why the Sialadeno-
ma occurs more often in the palate (20).
The SP is described in the literature as a typically slow 
growing lesion (13), a fact highlighted in our study, be-
cause the average progression time was 52 months. This 
narrow SP activity could be explained with low staining 
of Ki-67 (3), a nuclear protein that shows immunoreac-
tivity when the cell cycle is active.
Because SP is a rare condition, it is hardly ever repor-
ted as a diagnostic hypothesis (as seen in our results) 
and ends up being confused with more frequently occu-
rring lesions of the oral cavity, such as mucocele. Many 
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of these lesions present themselves as small exophytic 
nodules and are asymptomatic like SP, which makes 
it impossible to conclude diagnosis only with clinical 
information. According to the literature, a differential 
diagnosis of SP should include a check for other benign 
salivary gland tumors, such as inverted ductal papilloma 
and intraductal papilloma, and hyperplasia (7,12).  Besi-
des this paper, only two other cases cited a hypothetical 
diagnosis of mucocele (10,12). One of them was also on 
the lip mucosa (12). That being said, we can assume that 
histopathological examination is essential to confirm an 
SP diagnosis and to rule out the possibility of other si-
milar lesions.
To classify a lesion as SP in the histological analysis, 
we must identify superficial papillary projections that 
are lined by squamous epithelium and extend to sub-
mucosa to form cystic-like spaces (38). In the present 
case, the lesion met those criteria. It also presented acan-
thosis and parakeratosis as described in the literature 
(38). Some of our findings were also reported in other 
cases, such as chronic inflamation cells in connective 
tissue (3,10,12,30), epithelium with hyperkeratosis and 
parakeratosis (2,3,11,19,20), hyperplastic epithelium 
(2,19,26), epithelium with focal hypergranulosis (19), 
and spongiosis in squamous epithelium (19).
Besides the histological analysis, two additional exami-
nations were found in our review: PCR analysis and IHC 
examination. The HPV PCR Analysis was performed 
in only one study, and no hybridization of any of the 
HPV-specific probes was found (29). The IHC studies 
were performed to determine SP’s histogenesis, which 
is still unclear (4,10,18). The following antibodies were 
used in these studies : AE1/AE3, carcinoembryonic 
antigen (CEA), epithelial membrane antigen (EMA), 
cytokeratin (CK) 7, CK13, CK14, CK19, Ki-67, P40, 
P63, vimentin, smooth muscle actin (SMA), and SM-
100 (3,4,10,11,18,19,31). A normal salivary gland pre-
sents CKs 14, 13, 7, 8, and 19 (all of them found in the 
SP immunoprofile) but does not stain for vimentin or 
smooth muscle actin (18). The results for AE1/3, CEA, 
and EMA staining were also positive (19,31), yet the SP 
IHC exams for vimentin and SMA had different results 
among the cases, being positive in some and negative in 
others (3,10,18,19,31). These results could suggest that 
the tumor cells stem from various cell types such as duct 
cells and myoepithelial cells (3). Nonetheless, no article 
identified PCR or IHC examinations as routine parts of 
diagnoses.
With complete surgical removal, SP has a favorable 
prognosis, and in most cases no further treatment is 
required (10). According to Abrams and Finck, no evi-
dence exists of disease 1½ years following surgery (1). 
Nevertheless, due to a few recorded cases of recurrence, 
a long follow-up period is recommended to ensure that 
the lesion does not redevelop (3). The follow-up inter-
val and scope should be set individually. In the present 
case, a 17-month follow-up period showed satisfactory 
healing and no evidence of recurrence, similar to most 
of the consulted cases. However, in two cases in the oral 
cavity, the lesion recurred: with SP at the junction of the 
hard and soft palate after excisional biopsy, recurrence 
occurred at the 36-month follow-up (23); and with SP in 
the mucosal surface of the cheek after excisional biopsy, 
recurrence occurred at the 36-month follow-up (9). One 
of the consulted cases included a transoral robotic sur-
gery, introducing a new technology to remove SP le-
sions, which provides good hemostasis, less pain, and 
limited surgical morbidity (37). The downsides of this 
treatment, though, are the high costs and uncertainties 
regarding the new technology (37).
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Online Resource 1 Sialadenoma Papilliferum: Bibliometric Analysis. 
A bibliometric study of 36 articles from the PubMed platform about 
SP. The following indexes were taken into account: publishing coun-
try, patient race, age at diagnosis, patient gender, lesion occurrence 
site, lesion size, progression time, lesion color, symptoms, biopsy type, 
additional analysis, follow-up period, recurrence, and diagnostic hypo-
thesis.
